Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism

被引:142
作者
Qatanani, M [1 ]
Zhang, J [1 ]
Moore, DD [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
关键词
D O I
10.1210/en.2004-1350
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The induction of hepatic drug metabolizing enzymes alters not only the metabolism of the xenobiotic substances that induce them but also the metabolism of various endogenous hormones. The xenobiotic receptor constitutive androstane receptor ( CAR) (NR1I3) mediates the well-studied induction of CYP2B genes and other drug-metabolizing enzymes by phenobarbital (PB), an antiepileptic drug that has been shown to alter thyroid hormone (TH) levels. Here we show that CAR is required for PB-mediated disruption of TH homeostasis and the induction of thyroid follicular cell proliferation. Treatment with PB or the more potent and more effective CAR ligand 1, 4-bis-[2-(3,5,-dichloropyridyloxy)] benzene resulted in universal induction of thyroid hormone glucuronidation and sulfation pathways in a CAR-dependent manner. This resulted in a decrease in serum T-4 concentration and a concomitant increase in serum TSH levels. CAR activation also decreased serum T-3 levels in mice in which T-3 production was blocked. The increase in serum TSH levels resulted in the stimulation of thyroid-follicular cell proliferation. These results highlight the central role of the xenosensor CAR in drug-hormone interactions.
引用
收藏
页码:995 / 1002
页数:8
相关论文
共 92 条
[1]  
ABERNETHY DR, 1982, OBSTET GYNECOL, V60, P338
[2]   Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism [J].
Alexander, EK ;
Marqusee, E ;
Lawrence, J ;
Jarolim, P ;
Fischer, GA ;
Larsen, PR .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (03) :241-249
[3]   Increased need for thyroxine in women with hypothyroidism during estrogen therapy [J].
Arafah, BM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (23) :1743-1749
[4]   Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice [J].
Assem, M ;
Schuetz, EG ;
Leggas, M ;
Sun, DX ;
Yasuda, K ;
Reid, G ;
Zelcer, N ;
Adachi, M ;
Strom, S ;
Evans, RM ;
Moore, DD ;
Borst, P ;
Schuetz, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) :22250-22257
[5]   REDUCTION OF THYROID-HORMONE LEVELS AND ALTERATION OF THYROID-FUNCTION BY 4 REPRESENTATIVE UDP-GLUCURONOSYLTRANSFERASE INDUCERS IN RATS [J].
BARTER, RA ;
KLAASSEN, CD .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1994, 128 (01) :9-17
[6]   THYROXINE AND 3,3',5-TRIIODOTHYRONINE ARE GLUCURONIDATED IN RAT-LIVER BY DIFFERENT URIDINE DIPHOSPHATE-GLUCURONYLTRANSFERASES [J].
BEETSTRA, JB ;
VANENGELEN, JGM ;
KARELS, P ;
VANDERHOEK, HJ ;
DEJONG, M ;
DOCTER, R ;
KRENNING, EP ;
HENNEMANN, G ;
BROUWER, A ;
VISSER, TJ .
ENDOCRINOLOGY, 1991, 128 (02) :741-746
[7]   Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases [J].
Bianco, AC ;
Salvatore, D ;
Gereben, B ;
Berry, MJ ;
Larsen, PR .
ENDOCRINE REVIEWS, 2002, 23 (01) :38-89
[8]   THYROXINE REPLACEMENT REQUIREMENTS IN HYPOTHYROID PATIENTS RECEIVING PHENYTOIN [J].
BLACKSHEAR, JL ;
SCHULTZ, AL ;
NAPIER, JS ;
STUART, DD .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (03) :341-342
[9]   UDP-GLUCURONOSYLTRANSFERASES [J].
BURCHELL, B ;
COUGHTRIE, MWH .
PHARMACOLOGY & THERAPEUTICS, 1989, 43 (02) :261-289
[10]  
BURROW GN, 1994, NEW ENGL J MED, V331, P1072